Additional file 4: Figure S3. of MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF

BME scores of ACPA-positive patients with RA or UA (n = 123) with low, intermediate, or high levels of ACPA. Horizontal lines represent median. Whiskers show the 10th–90th percentile. Dots represent outliers. Baseline ACPA levels are shown categorically as low, intermediate, or high. The groups were as follows: low ≥7 U/ml, intermediate ≥167 U/ml, and high ≥327 U/ml. Low: n = 57; intermediate: n = 27; high: n = 39. ACPA anti-citrullinated protein antibodies, BME bone marrow edema. Kruskal-Wallis test, p = 0.23. (JPG 19 kb

Camptotheca acuminata Decne.

原著和名: カンレンボク科名: ヌマミズキ科 = Nyssaceae採集地: 愛知県 南設楽郡 鳳来町 愛知県林業試験場 (三河 南設楽郡 鳳来町 愛知県林業試験場)採集日: 1985/8/13採集者: 小林元男整理番号: JH026731国立科学博物館整理番号: TNS-VS-976731備考: 旱蓮

Additional file 6: Figure S6. of The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical

Showing association between age of onset and onset of symptoms within RA patients of the Leiden EAC. (a) Results of logistic regression analyses of age at RA onset in relation to the onset of symptoms. OR of 1.01 indicates that per 1-year increase in the age of onset, the odds of having (sub)acute onset increase 1%. This reflects 12% (1.0110) per 10-year increase in age of onset and 25% (1.0120) per 20-year increase in age of onset. (b) Proportion of RA patients with (sub)acute onset of symptoms in three age groups (p = 0.003). Number of patients per age group: <40, n = 181; 40–60, n = 466; >60, n = 537. (TIF 2476 kb